Tolerability profile of aripiprazole in patients with Tourette syndrome

Journal of Psychopharmacology

Volumn 26, Issue 6, 2012, Pages 891-895

  Cavanna, Andrea E ^a,b   Selvini, Claudia ^a,c   Termine, Cristiano ^c   Luoni, Chiara ^c   Eddy, Clare M ^a   Rickards, Hugh ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Adverse effects; aripiprazole; tics; tolerability; Tourette syndrome

Indexed keywords

ARIPIPRAZOLE;

ADULT; ADVERSE OUTCOME; ANOREXIA; ANXIETY DISORDER; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EJACULATION DISORDER; FEMALE; GILLES DE LA TOURETTE SYNDROME; HOT FLUSH; HUMAN; IRRITABILITY; MALE; METABOLIC DISORDER; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEDATION; SIDE EFFECT; SLEEP DISORDER; TREATMENT DURATION; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; QUINOLONES; RETROSPECTIVE STUDIES; TOURETTE SYNDROME; YOUNG ADULT;

EID: 84862154787     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111408462     Document Type: Article

References (27)

1. Albin RL, Mink JW. Recent advances in Tourette syndrome research. Trends Neurosci. 2006 ; 29: 175-182
2. Ben Djebara M, Worbe Y, Schopbach M, Hartmann A. Aripiprazole: a treatment for severe coprolalia in "refractory" Gilles de la Tourette syndrome. Mov Disord. 2008 ; 23: 438-440
3. Bubl E, Perlov E, Tebartz , Van Elst L. Aripiprazole in patients with Tourette syndrome. World J Biol Psychiatry. 2006 ; 7: 123-125
4. Budman C, Coffey BJ, Shechter R, et al. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. J Child Adolesc Psychopharmacol. 2008 ; 18: 509-515
5. Cavanna AE, Servo S, Monaco F, Robertson MM. The behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci. 2009 ; 21: 13-23
6. Constant EL, Borras L, Seghers A. Aripiprazole is effective in the treatment of Tourette's disorder. Int J Neuropsychopharmacol. 2006 ; 9: 773-774
7. Davies L, Stern JS, Agrawal N, Robertson MM. A case series of patients with Tourette's Syndrome in the UK treated with aripiprazole. Hum Psychopharmacol Clin Exp. 2006 ; 21: 447-453
8. Dehning S, Riedel M, Muller N. Aripiprazole in a patient vulnerable to side effects. Am J Psychiatry. 2005 ; 162: 625
9. Duane DD. Aripiprazole in childhood and adolescence for Tourette syndrome. J Child Neurol. 2006 ; 21: 358
10. Eddy CM, Rickards H, Cavanna AE. Treatment strategies for tics in Tourette syndrome. Ther Adv Neurol Dis. 2011 ; 4: 25-45
11. Fountoulakis KN, Siamouli M, Kantartzis S, et al. Acute dystonia with low-dosage aripiprazole in Tourette's disorder. Ann Pharmacother. 2006 ; 40: 775-777
12. Hood KK, Lourival BN, Beasley PJ, et al. Case study: Severe self-injurious behavior in comorbid Tourette's Disorder and OCD. J Am Acad Child Adolesc Psychiatry. 2004 ; 43: 1296-1303
13. Hounie A, De Mathis A, Sampaio AS, Mercadante MT. Aripiprazole and Tourette syndrome. Rev Bras Psiquiatr. 2004 ; 26: 213
14. Kastrup A, Schlotter W, Plewnia C, Bartels M. Treatment of tics in Tourette syndrome with aripiprazole. J Clin Psychopharmacol. 2005 ; 25: 94-96
15. Kawohl W, Schneider F, Vernaleken I, Neuner I. Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients. World J Biol Psychiatry. 2009a ; 10: 827-831
16. Kawohl W, Schneider F, Vernaleken I, Neuner I. Chronic motor tic disorder and aripiprazole. J Neuropsy Clin Neurosci. 2009b ; 21: 224
17. Lyon GJ, Samar S, Jummani R, et al. Aripiprazole in children and adolescents with Tourette's syndrome: An open-label safety and tolerability study. J Child Adolesc Psychopharmacol. 2009 ; 19: 623-633
18. Murphy TK, Bengtson MA, Soto O, et al. Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol. 2005 ; 8: 489-490
19. Padala PR, Qadri SF, Madaan V. Aripiprazole for the treatment of Tourette's disorder. Prim Care Companion J Clin Psychiatry. 2005 ; 7: 296-299
20. Pae CU. A review of the safety and tolerability of aripiprazole. Expert Opin Drug Saf. 2009 ; 8: 373-386
21. Robertson MM, Eapen V. The National Hospital Interview Schedule for the assessment of Giles de la Tourette syndrome. Int J Methods Psychiatr Res. 1996 ; 6: 203-226
22. Seo WS, Sung HM, Sea HS, Bai DS. Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder. J Child Adolesc Psychopharmacol. 2008 ; 18: 197-205
23. Singer HS, Szymanski S, Giuliano J, et al. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry. 2002 ; 159: 1329-1336
24. Singer HS. Treatment of tics and Tourette syndrome. Curr Treat Options Neurol. 2010 ; 12: 539-561
25. Winter C, Heinz A, Kupsch A, Strohle A. Aripiprazole in a case presenting with Tourette syndrome and obsessive-compulsive disorder. J Clin Psychopharm. 2008 ; 28: 452-454
26. Wood M, Reavill C. Aripiprazole acts as a selective dopamine D2 receptor partial agonist. Expert Opin Investig Drugs. 2007 ; 16: 771-775
27. Yoo HK, Kim JY, Kim CY. A pilot study of aripiprazole in children and adolescents with Tourette's disorder. J Child Adolesc Psychopharmacol. 2006 ; 16: 505-506